No photo of M Maral Mouradian

View Scopus Profile

M Maral Mouradian

 https://orcid.org/0000-0002-9937-412X
  • 12701 Citations
  • 58 h-Index
1986 …2022
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where M Maral Mouradian is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 10 Similar Profiles
Parkinson Disease Medicine & Life Sciences
Levodopa Medicine & Life Sciences
Synucleins Medicine & Life Sciences
Dopamine Receptors Medicine & Life Sciences
Dyskinesias Medicine & Life Sciences
Dopamine Medicine & Life Sciences
Genes Medicine & Life Sciences
Corpus Striatum Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2012 2022

Pp2A Dysregulation In The Pathogenesis Of Alpha-Synucleinopathies

Mouradian, M. M.

National Institutes of Health (NIH)

5/1/17 → 4/30/22

Project: Research project

Protein Phosphatase 2
Synucleins
Methylation
Serine
Virulence

Developing Novel Rna-Based Therapeutics For Parkinson'S Disease

Mouradian, M. M.

National Institutes of Health (NIH)

12/15/16 → 12/14/17

Project: Research project

Synucleins
Parkinson Disease
RNA
Therapeutics
Medical Genetics

Synergistic Neuroprotective Mechanisms Of Coffee Components In Parkinson'S Diseas

Mouradian, M. M.

National Institutes of Health (NIH)

9/30/12 → 8/31/18

Project: Research project

Coffee
Caffeine
Parkinson Disease
Dietary Supplements
Synucleins

Research Output 1986 2019

1 Citation (Scopus)

Nucleic Acid–Based Therapeutics for Parkinson’s Disease

Nakamori, M., Junn, E., Mochizuki, H. & Mouradian, M. M., Apr 15 2019, In : Neurotherapeutics. 16, 2, p. 287-298 12 p.

Research output: Contribution to journal › Review article

Synucleins
Parkinson Disease
Dopamine
Dopaminergic Neurons
Small Interfering RNA

Role of striatal ΔFosB in L-Dopa–induced dyskinesias of parkinsonian nonhuman primates

Beck, G., Singh, A., Zhang, J., Potts, L. F., Woo, J. M., Park, E. S., Mochizuki, H., Mouradian, M. M. & Papa, S. M., Sep 10 2019, In : Proceedings of the National Academy of Sciences of the United States of America. 116, 37, p. 18664-18672 9 p.

Research output: Contribution to journal › Article

Open Access
Corpus Striatum
Dyskinesias
Primates
Levodopa
Dopamine
25 Citations (Scopus)

Cytoprotective mechanisms of DJ-1 against oxidative stress through modulating ERK1/2 and ASK1 signal transduction

Oh, S. E. & Mouradian, M. M., Apr 1 2018, In : Redox Biology. 14, p. 211-217 7 p.

Research output: Contribution to journal › Review article

MAP Kinase Kinase Kinase 5
Signal transduction
Oxidative stress
Signal Transduction
Oxidative Stress
4 Citations (Scopus)

Protein phosphatase 2A and its methylation modulating enzymes LCMT-1 and PME-1 are dysregulated in tauopathies of progressive supranuclear palsy and Alzheimer disease

Park, H. J., Lee, K. W., Oh, S., Yan, R., Zhang, J., Beach, T. G., Adler, C. H., Voronkov, M., Braithwaite, S. P., Stock, J. B. & Mouradian, M. M., Feb 1 2018, In : Journal of Neuropathology and Experimental Neurology. 77, 2, p. 139-148 10 p., nlx110.

Research output: Contribution to journal › Article

Tauopathies
Progressive Supranuclear Palsy
Protein Phosphatase 2
Methylation
Alzheimer Disease
1 Citation (Scopus)

Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson’s disease and DLB

Yan, R., Zhang, J., Park, H. J., Park, E. S., Oh, S., Zheng, H., Junn, E., Voronkov, M., Stock, J. B. & Mouradian, M. M., Dec 18 2018, In : Proceedings of the National Academy of Sciences of the United States of America. 115, 51, p. E12053-E12062

Research output: Contribution to journal › Article

Synucleins
Lewy Body Disease
Coffee
Caffeine
Protein Phosphatase 2